IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 101 - 112 of 1451 stories.
January 20, 2016
Albany Molecular Research Inc. (AMRI; Albany, NY) says that Dawn Von Rohr will join AMRI as senior v.p./active pharmaceutical ingredient (API) business, effective 25 January. Von Rohr...
January 20, 2016
Altivia (Houston) has added capacity for the production of chloroacetyl chloride at its La Porte, TX, site by continuous phosgenation. Chloroacetyl chloride, a feedstock for the production of pharmaceuticals and agrochemicals, is now available in bulk from the La Porte facility, the company says....
January 20, 2016
Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) says that it has relocated development and clinical manufacturing services from Nottingham to Queenborough, UK. Aesica will now provide...
January 20, 2016
Johnson Matthey says it has expanded the R&D facilities at its Cambridge, UK, location. Capacity has been added in process R&D and in non-GMP production on a kilogram scale of...
January 19, 2016
Ampac Fine Chemicals today announced that Aslam Malik has been named president and CEO, effective 1 January. Malik replaces Joseph Carleone, who will remain as chairmand of Ampac's...
January 19, 2016
FDA issues warning letter to Hisun’s API plant in China The US FDA issued a warning letter on 31 December 2015 to the active pharmaceutical ingredient (API) manufacturing...
January 14, 2016
Lonza said on Wednesday that it is expanding mammalian production capacity at its Slough, UK facility. Based on increased demand for biopharmaceutical development and clinical...
January 13, 2016
The US FDA issued a warning letter on 31 December 2015 to the active pharmaceutical ingredient (API) manufacturing facility of Zhejiang Hisun Pharmaceutical—located at Taizhou...
January 12, 2016
Bayer has opened a large manufacturing site of traditional Chinese medicine (TCM) and Western medicine in the Majinpu bioengineering and pharmaceutical industrial park at Yunnan...
January 12, 2016
SAFC’s Gilles Cottier joins Patheon as head of pharmaceutical development services Patheon (Durham, NC), a provider of outsourced pharmaceutical development and manufacturing...
January 11, 2016
Patheon (Durham, NC), a provider of outsourced pharmaceutical development and manufacturing services, says that it has appointed Gilles Cottier as president of the company’s...
January 5, 2016
Pharmaceutical company Cadila Healthcare (Ahmedabad, India) informed the Bombay Stock Exchange (Mumbai) on 31 December 2015 that it has received a warning letter from the US FDA...
Pages: « Previous  2 3 4 5 6 7 8 9 10 [11] 12 13 14 15 16 17 18 19 20 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa